Elcelyx Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • OTC, Consumer
    • Nutraceuticals
  • Biotechnology
See more in Biomedtracker

Latest on Elcelyx Therapeutics, Inc.

Scrip

Venture Funding Deals: Two Companies With China Ties Raise $260m Each

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Scrip

Finance Watch: Lots Of Money, Big And Small, Flowing Into Drug Development

 
• By Mandy Jackson

The frenzied flow of funds into biopharma venture capital has resulted in a lot of big bets, but recent small financings are encouraging as cash is harder to come by at the earliest stages of drug dis

In Vivo

Execs On The Move, December 2016

 
• By Regina Paleski

Company Changes BISHOP , Kathie M., PhD To: Otonomy Inc. , CSO (November) From: Tioga Pharmaceuticals, CSO Phone: 858-242-5200 BOGATYRENKO , Yulii To: TherapeuticsMD Inc. , SVP, Bus. Dev.

Scrip

Pipeline Watch: Phase III Progress In Cystic Fibrosis, Spinal Muscular Atrophy And Melanoma

 
• By John Davis

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between November 4 and November 10, 2016,